MBD1 antibody
Quick Overview for MBD1 antibody (ABIN7881626)
Target
See all MBD1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- MBD1 Antibody
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for the MBD1 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the MBD1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the MBD1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MBD1 (Methyl-CpG Binding Domain Protein 1 (MBD1))
-
Alternative Name
- MBD1
-
Background
- DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. MBD1 has also been predicted to be involved in the development and progression of tumors, and it has been shown that MBD1 is significantly upregulated in pancreatic cancer tissues when compared with surrounding normal tissues. Furthermore, MBD1 may serve as a potential therapeutic target for pancreatic cancer.
-
UniProt
- Q9UIS9
Target
-